Mira Pharmaceuticals, Inc.
MIRANasdaqCIK 1904286Healthcare
Reports and events: 102 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2212:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-048022 |
| 2026-09-1712:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-043051 |
| 2026-09-1620:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-042927 |
| 2026-09-0112:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-040930 |
| 2026-08-1220:17 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037366 |
| 2026-08-0612:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-036262 |
| 2026-07-3121:00 ET | 8-K | 3.01 Delisting notice | 0001493152-26-035665 |
| 2026-07-2821:00 ET | DEF 14A | Proxy statementPeriod 2026-07-28 | 0001493152-26-035027 |
| 2026-07-1012:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-032777 |
| 2026-07-0613:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-032091 |
| 2026-06-2512:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030033 |
| 2026-06-1712:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028992 |
| 2026-06-0821:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-027751 |
| 2026-06-0412:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027202 |
| 2026-05-2712:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-025335 |
| 2026-05-1419:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-023005 |
| 2026-05-1320:01 ET | 8-K | 7.01 Regulation FD disclosure | 0001493152-26-022704 |
| 2026-05-1311:30 ET | 8-K | 8.01 Other events | 0001493152-26-022608 |
| 2026-03-3118:02 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-014001 |
| 2026-03-2313:00 ET | 8-K | 8.01 Other events | 0001493152-26-012085 |
| 2026-03-0321:01 ET | 8-K | 8.01 Other events | 0001493152-26-008707 |
| 2026-02-0221:01 ET | 8-K | 8.01 Other events | 0001493152-26-004739 |
| 2025-12-2201:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-25-028619 |
| 2025-12-0522:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-026445 |
| 2025-11-1312:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-022112 |
| 2025-10-2320:01 ET | 8-K | 8.01 Other events | 0001493152-25-019065 |
| 2025-10-1620:01 ET | 8-K | 8.01 Other events | 0001493152-25-018303 |
| 2025-10-1520:01 ET | 8-K | 8.01 Other events | 0001493152-25-018141 |
| 2025-09-3011:00 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-016168 |
| 2025-09-2211:30 ET | 8-K | 8.01 Other events | 0001493152-25-014393 |
| 2025-09-1520:02 ET | 8-K | 8.01 Other events | 0001493152-25-013459 |
| 2025-09-1121:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-013100 |
| 2025-08-1912:00 ET | 8-K | 8.01 Other events | 0001641172-25-024731 |
| 2025-08-1420:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024077 |
| 2025-08-1212:00 ET | 8-K | 8.01 Other events | 0001641172-25-023110 |
| 2025-07-2920:01 ET | 8-K | 8.01 Other events | 0001641172-25-021356 |
| 2025-07-2820:01 ET | 8-K | 8.01 Other events | 0001641172-25-021155 |
| 2025-07-1020:19 ET | 8-K | 8.01 Other events | 0001641172-25-018595 |
| 2025-07-0821:25 ET | 8-K | 8.01 Other events | 0001641172-25-018247 |
| 2025-07-0220:06 ET | 8-K | 8.01 Other events | 0001641172-25-017557 |
| 2025-06-3011:30 ET | 8-K | 8.01 Other events | 0001641172-25-017046 |
| 2025-06-2420:01 ET | 8-K | 8.01 Other events | 0001641172-25-016285 |
| 2025-06-1720:01 ET | 8-K | 8.01 Other events | 0001641172-25-015401 |
| 2025-05-2812:00 ET | 8-K | 8.01 Other events | 0001641172-25-012603 |
| 2025-05-2121:25 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001641172-25-011936 |
| 2025-05-1420:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-010301 |
| 2025-05-0811:30 ET | 8-K | 8.01 Other events | 0001641172-25-009155 |
| 2025-05-0611:30 ET | 8-K | 8.01 Other events | 0001641172-25-008748 |
| 2025-04-2311:30 ET | 8-K | 8.01 Other events | 0001641172-25-005772 |
| 2025-04-1721:28 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001641172-25-005313 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.